United Therapeutics (UTHR) Tops Q1 EPS by 32c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $598.72 +0.87%
Revenue Growth %: -1.8%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -1.8%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $4.86, $0.32 better than the analyst estimate of $4.54. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $512.69 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Freedom Broker Downgrades RPC Inc. (RES) to Sell
- Goldman Sachs Revises China Jewelry Stocks Amid Gold Price Retreat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
